Jane Ong
9Patents
2h-index
18Co-inventors
40Inventor score
Filing activity: Jan 6, 2011 → Feb 4, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9273031B2 | Combination therapy with MDM2 and EFGR inhibitors | Chemistry; Metallurgy | 12 | Active |
| US8658170B2 | Combination therapy with MDM2 and EFGR inhibitors | Chemistry; Metallurgy | 4 | Active |
| US8618302B2 | Methods and compositions of targeted drug development | Physics | 1 | Active |
| US10213374B2 | Oral care compositions and methods of use | Human Necessities | 1 | Active |
| US10548829B2 | Oral care compositions and methods of use | Human Necessities | 1 | Active |
| US9073858B2 | Methods of targeted drug development | Physics | 0 | Active |
| US11116708B2 | Personal care compositions including naringin:zinc complexes and methods for the same | Human Necessities | 0 | Active |
| US9023354B2 | Combination therapy with MDM2 and EFGR inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9238641B2 | Combination therapy with MDM2 and EFGR inhibitors | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.